Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo
This study assessed the duration of action of single doses of ranitidine (75 mg), cimetidine (200 mg), or placebo on intragastric acidity in healthy subjects. When dosed with placebo, mean daytime intragastric acidity (0-10 hr after dose) was 37.62 mmol/liter, decreasing to 17.21 mmol/liter (mean de...
Gespeichert in:
Veröffentlicht in: | Digestive diseases and sciences 2002, Vol.47 (1), p.54-57 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 57 |
---|---|
container_issue | 1 |
container_start_page | 54 |
container_title | Digestive diseases and sciences |
container_volume | 47 |
creator | HAMILTON, Mark I SERCOMBE, Judy POUNDER, Roy E |
description | This study assessed the duration of action of single doses of ranitidine (75 mg), cimetidine (200 mg), or placebo on intragastric acidity in healthy subjects. When dosed with placebo, mean daytime intragastric acidity (0-10 hr after dose) was 37.62 mmol/liter, decreasing to 17.21 mmol/liter (mean decrease 59%; P < 0.001 vs placebo) and 25.06 mmol/liter (mean decrease 35%; P < 0.001 vs placebo) when treated with ranitidine and cimetidine, respectively. Ranitidine inhibited intragastric acidity to a greater degree than cimetidine (P < 0.001). Mean nighttime (10-20 hr after-dose) intragastric acidity when dosed with placebo was 34.37 mmol/liter, decreasing to 29.06 mmol/liter (mean decrease 18%; P = 0.027 vs placebo) when dosed with ranitidine and remaining virtually unchanged at 33.85 mmol/liter (mean decrease 2%; NS vs. placebo) when dosed with cimetidine. Ranitidine inhibited acidity to a greater degree than cimetidine (P = 0.043). The inhibitory effect of ranitidine, 75 mg, on intragastric acidity can be detected from 0-15 hr after an oral dose. Cimetidine 200 mg has little inhibitory effect beyond 10 hr. |
doi_str_mv | 10.1023/A:1013255201858 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71446331</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71446331</sourcerecordid><originalsourceid>FETCH-LOGICAL-p264t-44bd78a97a646617c50dc8c0a6305800157b195740d3fcec0f4cb3b061fb8b723</originalsourceid><addsrcrecordid>eNpd0MtrHDEMB2BTGppN0nNvxQSaUzaR_N7cQt4Q6KU9D7bHk_Uyj43toex_H9NuCPQk8eNDSCLkG8IFAuOX11cIyJmUDNBI84ksUGq-ZFKZz2QBqGqPqA7JUc4bAFhpVF_IIaLhWnO2INNt8CnYHOjU0TiWZF9sLil6an1sY9nVkK6D7ct6R_PsNsGXTNsph5b-iWVNkx1jqXIMVEs6vJxTH4ewTxjA32hKdNtbH9x0Qg462-fwdV-Pye_7u183j8vnnw9PN9fPyy1ToiyFcK02dqWtEkqh9hJabzxYxUEagHqlw5XUAlre-eChE95xBwo7Z5xm_Jic_Zu7TdPrHHJphph96Hs7hmnOjUYhFOdY4el_cDPNaay7NQwFF8iVqej7Hs1uCG2zTXGwade8_7GCH3tgs7d9V7_iY_5wXCitjOFvUPJ_vA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214341368</pqid></control><display><type>article</type><title>Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>HAMILTON, Mark I ; SERCOMBE, Judy ; POUNDER, Roy E</creator><creatorcontrib>HAMILTON, Mark I ; SERCOMBE, Judy ; POUNDER, Roy E</creatorcontrib><description>This study assessed the duration of action of single doses of ranitidine (75 mg), cimetidine (200 mg), or placebo on intragastric acidity in healthy subjects. When dosed with placebo, mean daytime intragastric acidity (0-10 hr after dose) was 37.62 mmol/liter, decreasing to 17.21 mmol/liter (mean decrease 59%; P < 0.001 vs placebo) and 25.06 mmol/liter (mean decrease 35%; P < 0.001 vs placebo) when treated with ranitidine and cimetidine, respectively. Ranitidine inhibited intragastric acidity to a greater degree than cimetidine (P < 0.001). Mean nighttime (10-20 hr after-dose) intragastric acidity when dosed with placebo was 34.37 mmol/liter, decreasing to 29.06 mmol/liter (mean decrease 18%; P = 0.027 vs placebo) when dosed with ranitidine and remaining virtually unchanged at 33.85 mmol/liter (mean decrease 2%; NS vs. placebo) when dosed with cimetidine. Ranitidine inhibited acidity to a greater degree than cimetidine (P = 0.043). The inhibitory effect of ranitidine, 75 mg, on intragastric acidity can be detected from 0-15 hr after an oral dose. Cimetidine 200 mg has little inhibitory effect beyond 10 hr.</description><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1023/A:1013255201858</identifier><identifier>PMID: 11837732</identifier><identifier>CODEN: DDSCDJ</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adult ; Anti-Ulcer Agents - administration & dosage ; Anti-Ulcer Agents - pharmacology ; Biological and medical sciences ; Cimetidine - administration & dosage ; Cimetidine - pharmacology ; Digestive system ; Gastric Acid - metabolism ; Gastric Acidity Determination ; Histamine H2 Antagonists - pharmacology ; Humans ; Hydrogen-Ion Concentration ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Ranitidine - administration & dosage ; Ranitidine - pharmacology</subject><ispartof>Digestive diseases and sciences, 2002, Vol.47 (1), p.54-57</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Kluwer Academic Publishers Jan 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13467688$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11837732$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HAMILTON, Mark I</creatorcontrib><creatorcontrib>SERCOMBE, Judy</creatorcontrib><creatorcontrib>POUNDER, Roy E</creatorcontrib><title>Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><description>This study assessed the duration of action of single doses of ranitidine (75 mg), cimetidine (200 mg), or placebo on intragastric acidity in healthy subjects. When dosed with placebo, mean daytime intragastric acidity (0-10 hr after dose) was 37.62 mmol/liter, decreasing to 17.21 mmol/liter (mean decrease 59%; P < 0.001 vs placebo) and 25.06 mmol/liter (mean decrease 35%; P < 0.001 vs placebo) when treated with ranitidine and cimetidine, respectively. Ranitidine inhibited intragastric acidity to a greater degree than cimetidine (P < 0.001). Mean nighttime (10-20 hr after-dose) intragastric acidity when dosed with placebo was 34.37 mmol/liter, decreasing to 29.06 mmol/liter (mean decrease 18%; P = 0.027 vs placebo) when dosed with ranitidine and remaining virtually unchanged at 33.85 mmol/liter (mean decrease 2%; NS vs. placebo) when dosed with cimetidine. Ranitidine inhibited acidity to a greater degree than cimetidine (P = 0.043). The inhibitory effect of ranitidine, 75 mg, on intragastric acidity can be detected from 0-15 hr after an oral dose. Cimetidine 200 mg has little inhibitory effect beyond 10 hr.</description><subject>Adult</subject><subject>Anti-Ulcer Agents - administration & dosage</subject><subject>Anti-Ulcer Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cimetidine - administration & dosage</subject><subject>Cimetidine - pharmacology</subject><subject>Digestive system</subject><subject>Gastric Acid - metabolism</subject><subject>Gastric Acidity Determination</subject><subject>Histamine H2 Antagonists - pharmacology</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Ranitidine - administration & dosage</subject><subject>Ranitidine - pharmacology</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpd0MtrHDEMB2BTGppN0nNvxQSaUzaR_N7cQt4Q6KU9D7bHk_Uyj43toex_H9NuCPQk8eNDSCLkG8IFAuOX11cIyJmUDNBI84ksUGq-ZFKZz2QBqGqPqA7JUc4bAFhpVF_IIaLhWnO2INNt8CnYHOjU0TiWZF9sLil6an1sY9nVkK6D7ct6R_PsNsGXTNsph5b-iWVNkx1jqXIMVEs6vJxTH4ewTxjA32hKdNtbH9x0Qg462-fwdV-Pye_7u183j8vnnw9PN9fPyy1ToiyFcK02dqWtEkqh9hJabzxYxUEagHqlw5XUAlre-eChE95xBwo7Z5xm_Jic_Zu7TdPrHHJphph96Hs7hmnOjUYhFOdY4el_cDPNaay7NQwFF8iVqej7Hs1uCG2zTXGwade8_7GCH3tgs7d9V7_iY_5wXCitjOFvUPJ_vA</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>HAMILTON, Mark I</creator><creator>SERCOMBE, Judy</creator><creator>POUNDER, Roy E</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>2002</creationdate><title>Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo</title><author>HAMILTON, Mark I ; SERCOMBE, Judy ; POUNDER, Roy E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p264t-44bd78a97a646617c50dc8c0a6305800157b195740d3fcec0f4cb3b061fb8b723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Anti-Ulcer Agents - administration & dosage</topic><topic>Anti-Ulcer Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cimetidine - administration & dosage</topic><topic>Cimetidine - pharmacology</topic><topic>Digestive system</topic><topic>Gastric Acid - metabolism</topic><topic>Gastric Acidity Determination</topic><topic>Histamine H2 Antagonists - pharmacology</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Ranitidine - administration & dosage</topic><topic>Ranitidine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HAMILTON, Mark I</creatorcontrib><creatorcontrib>SERCOMBE, Judy</creatorcontrib><creatorcontrib>POUNDER, Roy E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HAMILTON, Mark I</au><au>SERCOMBE, Judy</au><au>POUNDER, Roy E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo</atitle><jtitle>Digestive diseases and sciences</jtitle><addtitle>Dig Dis Sci</addtitle><date>2002</date><risdate>2002</risdate><volume>47</volume><issue>1</issue><spage>54</spage><epage>57</epage><pages>54-57</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><coden>DDSCDJ</coden><abstract>This study assessed the duration of action of single doses of ranitidine (75 mg), cimetidine (200 mg), or placebo on intragastric acidity in healthy subjects. When dosed with placebo, mean daytime intragastric acidity (0-10 hr after dose) was 37.62 mmol/liter, decreasing to 17.21 mmol/liter (mean decrease 59%; P < 0.001 vs placebo) and 25.06 mmol/liter (mean decrease 35%; P < 0.001 vs placebo) when treated with ranitidine and cimetidine, respectively. Ranitidine inhibited intragastric acidity to a greater degree than cimetidine (P < 0.001). Mean nighttime (10-20 hr after-dose) intragastric acidity when dosed with placebo was 34.37 mmol/liter, decreasing to 29.06 mmol/liter (mean decrease 18%; P = 0.027 vs placebo) when dosed with ranitidine and remaining virtually unchanged at 33.85 mmol/liter (mean decrease 2%; NS vs. placebo) when dosed with cimetidine. Ranitidine inhibited acidity to a greater degree than cimetidine (P = 0.043). The inhibitory effect of ranitidine, 75 mg, on intragastric acidity can be detected from 0-15 hr after an oral dose. Cimetidine 200 mg has little inhibitory effect beyond 10 hr.</abstract><cop>Heidelberg</cop><pub>Springer</pub><pmid>11837732</pmid><doi>10.1023/A:1013255201858</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0163-2116 |
ispartof | Digestive diseases and sciences, 2002, Vol.47 (1), p.54-57 |
issn | 0163-2116 1573-2568 |
language | eng |
recordid | cdi_proquest_miscellaneous_71446331 |
source | MEDLINE; SpringerLink Journals |
subjects | Adult Anti-Ulcer Agents - administration & dosage Anti-Ulcer Agents - pharmacology Biological and medical sciences Cimetidine - administration & dosage Cimetidine - pharmacology Digestive system Gastric Acid - metabolism Gastric Acidity Determination Histamine H2 Antagonists - pharmacology Humans Hydrogen-Ion Concentration Male Medical sciences Pharmacology. Drug treatments Ranitidine - administration & dosage Ranitidine - pharmacology |
title | Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T06%3A19%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decrease%20of%20intragastric%20acidity%20in%20healthy%20subjects%20dosed%20with%20ranitidine%2075%20mg,%20cimetidine%20200%20mg,%20or%20placebo&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=HAMILTON,%20Mark%20I&rft.date=2002&rft.volume=47&rft.issue=1&rft.spage=54&rft.epage=57&rft.pages=54-57&rft.issn=0163-2116&rft.eissn=1573-2568&rft.coden=DDSCDJ&rft_id=info:doi/10.1023/A:1013255201858&rft_dat=%3Cproquest_pubme%3E71446331%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=214341368&rft_id=info:pmid/11837732&rfr_iscdi=true |